Pfizer : PFE

All Pfizer Articles

1465 Articles

Trey Thoelcke | Dec 26, 2019 at 6:40 AM EST

The 6 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Microsoft, Pfizer and Intel above all other Dow stocks.

Chris Lange | Dec 23, 2019 at 11:00 AM EST

The Top Biopharma Calendar Events to Watch Going Into 2020

Here, 24/7 Wall St. has included a calendar of a few of the biggest clinical trial and FDA updates to…

Jon C. Ogg | Dec 13, 2019 at 12:25 PM EST

Meet the Preliminary 2020 Dogs of the Dow

One theme that investors love in good times and in bad is dividend investing. One strategy that has been around…

Chris Lange | Dec 11, 2019 at 9:45 AM EST

Big Pharma Short Sellers Grow More Selective

The November 29 short interest data have been compared with the previous figures, and short interest moves in these selected…

Trey Thoelcke | Dec 11, 2019 at 7:10 AM EST

The 6 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Apple, Microsoft and Intel above all other Dow stocks.

Chris Lange | Nov 27, 2019 at 9:00 AM EST

Big Pharma Short Sellers Hike Their Bets

The November 15 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Nov 18, 2019 at 10:50 AM EST

How Dow 28,000 Can Rapidly Become Dow 30,000 and Even Higher in 2020

Despite the never-ending election cycle, there actually is a clear path for the Dow to hit 30,000 as soon as…

Chris Lange | Nov 12, 2019 at 8:50 AM EST

Big Pharma Scares Off Short Sellers

The October 31 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Nov 12, 2019 at 7:05 AM EST

The 5 Most Shorted Dow Stocks

As of the most recently reported settlement date, short sellers still favored Microsoft, Intel and Pfizer above all other Dow…

Jon C. Ogg | Nov 4, 2019 at 11:20 AM EST

As the Dow Hits All-Time High, Over Half of Dow Stocks Keep Disappointing Investors

With markets at all-time highs, it's important to consider the winners and losers. In this case, many stocks in the…

Chris Lange | Oct 29, 2019 at 10:20 AM EDT

Is This the Turnaround Pfizer and Merck Shareholders Have Been Waiting For?

Shares of Merck and Pfizer both got boosts after they reported their most recent quarterly results before the opening bell…

Chris Lange | Oct 28, 2019 at 1:25 PM EDT

Merck and Pfizer Earnings: What to Expect

Merck and Pfizer are set to report their most recent quarterly results before the opening bell tomorrow. Pfizer is one…

Chris Lange | Oct 27, 2019 at 6:50 AM EDT

Apple, Chevron, Exxon, Pfizer and More Dow Earnings Coming This Week

Six of the 30 Dow Jones industrial average components are scheduled to report their latest quarterly reports this week.

Chris Lange | Oct 25, 2019 at 9:59 AM EDT

Short Sellers Can’t Make Up Their Minds on Big Pharma

The October 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Trey Thoelcke | Oct 25, 2019 at 7:05 AM EDT

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers still favored Microsoft, Intel and Pfizer above all other Dow stocks.

1 … 23 24 25 26 27 … 98

Pfizer : PFE

All Pfizer Articles

The 6 Most Shorted Dow Stocks

The Top Biopharma Calendar Events to Watch Going Into 2020

Meet the Preliminary 2020 Dogs of the Dow

Big Pharma Short Sellers Grow More Selective

The 6 Most Shorted Dow Stocks

Big Pharma Short Sellers Hike Their Bets

How Dow 28,000 Can Rapidly Become Dow 30,000 and Even Higher in 2020

Big Pharma Scares Off Short Sellers

The 5 Most Shorted Dow Stocks

As the Dow Hits All-Time High, Over Half of Dow Stocks Keep Disappointing Investors

Is This the Turnaround Pfizer and Merck Shareholders Have Been Waiting For?

Merck and Pfizer Earnings: What to Expect

Apple, Chevron, Exxon, Pfizer and More Dow Earnings Coming This Week

Short Sellers Can’t Make Up Their Minds on Big Pharma

The 5 Most Shorted Dow Stocks

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Donald Trump’s Truth Social Stake Hit $4 Billion. Everyday Investors Who Chased the ‘DJT’ Meme Stock Have Watched Billions Evaporate

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Pfizer : PFE

All Pfizer Articles

The 6 Most Shorted Dow Stocks

The Top Biopharma Calendar Events to Watch Going Into 2020

Meet the Preliminary 2020 Dogs of the Dow

Big Pharma Short Sellers Grow More Selective

The 6 Most Shorted Dow Stocks

Big Pharma Short Sellers Hike Their Bets

How Dow 28,000 Can Rapidly Become Dow 30,000 and Even Higher in 2020

Big Pharma Scares Off Short Sellers

The 5 Most Shorted Dow Stocks

As the Dow Hits All-Time High, Over Half of Dow Stocks Keep Disappointing Investors

Is This the Turnaround Pfizer and Merck Shareholders Have Been Waiting For?

Merck and Pfizer Earnings: What to Expect

Apple, Chevron, Exxon, Pfizer and More Dow Earnings Coming This Week

Short Sellers Can’t Make Up Their Minds on Big Pharma

The 5 Most Shorted Dow Stocks

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Featured Reads

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts